2022
DOI: 10.1016/j.jimed.2022.04.002
|View full text |Cite
|
Sign up to set email alerts
|

Diagnosis of hepatic inflammatory pseudotumor by fine-needle biopsy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
0
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 14 publications
0
0
0
Order By: Relevance
“…Moreover, since neither imaging modalities nor biochemical tests provide conclusive evidence of IPT [15], it is not easy to distinguish IPT from malignant liver tumors including hepatocellular carcinoma, Diagnostics 2023, 13, 2857 2 of 13 cholangiocellular carcinoma, cholangiolocellular carcinoma and metastatic liver cancer. Indeed, liver tumor markers such as AFP, PIVKA II, and CEA were almost within normal limits in the reported references [16,17]; however, liver function tests such as ALT and AST showed multifield increases due to inflammation in the reported references [17].…”
Section: Introductionmentioning
confidence: 85%
“…Moreover, since neither imaging modalities nor biochemical tests provide conclusive evidence of IPT [15], it is not easy to distinguish IPT from malignant liver tumors including hepatocellular carcinoma, Diagnostics 2023, 13, 2857 2 of 13 cholangiocellular carcinoma, cholangiolocellular carcinoma and metastatic liver cancer. Indeed, liver tumor markers such as AFP, PIVKA II, and CEA were almost within normal limits in the reported references [16,17]; however, liver function tests such as ALT and AST showed multifield increases due to inflammation in the reported references [17].…”
Section: Introductionmentioning
confidence: 85%